Bedside Percutaneous Dilatational Tracheostomy by Griggs Technique: A Single-Center Experience

Area of Science:

• Critical Care Medicine
• Surgical Procedures
• Respiratory Therapy

Background:

• Percutaneous dilatational tracheostomy (PDT) is a common procedure in intensive care units (ICUs).
• The Griggs' method is a specific technique used for performing PDT at the bedside.
• Evaluating the reliability and outcomes of this method is crucial for patient management.

Purpose of the Study:

• To assess the reliability and outcomes of percutaneous dilatational tracheostomy (PDT) using the Griggs' method.
• To evaluate complication rates, mortality, and morbidity associated with bedside PDT.
• To determine the impact of PDT on patient comfort and ventilator weaning.

Main Methods:

• A retrospective study of 78 patients who underwent bedside PDT in the ICU.
• Data collection included demographic characteristics, indications for ICU admission, and procedure duration.
• Assessment of outcomes included ventilator-associated pneumonia, complication rates, and mortality.

Main Results:

• The mean age of patients was 68.7 years, with pneumonia being the most common indication for ICU admission.
• The mean duration for PDT was 21 minutes, and 91% of patients did not require sedation post-procedure.
• The overall complication rate was 37.1%, with bleeding being the most frequent early complication.

Conclusions:

• Percutaneous dilatational tracheostomy (PDT) is a reliable bedside procedure with a shortened duration and accelerated wound healing.
• PDT offers significant advantages, including improved patient comfort, facilitated ventilator weaning, and enhanced pulmonary secretion clearance.
• The Griggs' method demonstrates a low rate of complications, making it a valuable option in intensive care settings.